Roivant Sciences (ROIV) Depreciation & Amortization (CF) (2021 - 2026)

Roivant Sciences (ROIV) has 5 years of Depreciation & Amortization (CF) data on file, last reported at $2.7 million in Q4 2025.

• Quarterly Depreciation & Amortization (CF) fell 78.57% year-over-year to $2.7 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $4.7 million (down 78.86% YoY) and the FY2026 annual result came in at $3.3 million, down 76.21% from the prior year.
• Depreciation & Amortization (CF) climbed to $2.7 million in Q4 2025, from $921000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $16.8 million in Q4 2023 to a low of $921000.0 in Q3 2025.
• A 5-year average of $6.2 million and a median of $4.9 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 205.35% — and 2025, when it slumped 80.98%.
• Tracing ROIV's Depreciation & Amortization (CF) over 5 years: stood at $4.2 million in 2021, then soared by 205.35% to $12.9 million in 2022, then jumped by 30.28% to $16.8 million in 2023, then fell by 24.78% to $12.6 million in 2024, then tumbled by 78.57% to $2.7 million in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $2.7 million (Q4 2025), $921000.0 (Q3 2025), and $1.1 million (Q2 2025), per Business Quant data.